Thomas Meier, PhD
Managing Partner
Thomas is a dynamic life-science entrepreneur who established Santhera Pharmaceuticals (SIX Exchange: SANN) as successful Biotech/Specialty Pharma company in the Basel area (Switzerland). In the past 20 years he held executive manager positions (CSO and CEO) at Santhera and successfully executed merger/acquisitions, product licensing and turn-around situations.
He stepped down as Santhera’s CEO in late 2019 and became Managing Partner at Viopas Venture Consulting in 2020. Currently Thomas holds four Board positions.
Thomas has a PhD in Biology and is lecturer in neurosciences at the Biozentrum, University of Basel. He is an internationally recognized scientist with track record in clinical research of orphan diseases.
Chairman of the Board
Public company (Basel)
Dedicated to treatments of rare diseases
Member of the Board
Private Company (Basel, Israel)
Treatment of neuropathic pain
Member of the Board
Private Company (San Diego)
Treatment of ophthalmic diseases
Co-Founder and Chairman of the Board
Private Company (Basel)
Gene therapy for muscular dystrophy